The clinical practice of assessing and regulating the concentration of hormones in the circulation that are unbound to carrier proteins, such as sex hormone-binding globulin (SHBG) or albumin. This unbound portion, the “free fraction,” represents the biologically active hormone pool available to diffuse into tissues and bind to intracellular receptors to exert its physiological effect. Effective management focuses on optimizing this fraction, not just total hormone levels.
Origin
This concept is rooted in the principles of protein-ligand binding and endocrinology, recognizing that total hormone measurements often fail to accurately reflect the true biological availability or tissue exposure. The clinical emphasis on the free fraction emerged with the advent of reliable and accurate assays capable of measuring these minute concentrations. It is a cornerstone of precision hormone optimization.
Mechanism
The management strategy involves adjusting exogenous hormone dosing or employing specific agents to modulate the synthesis or binding capacity of carrier proteins like SHBG, which is predominantly produced by the liver. For instance, increasing free testosterone involves ensuring adequate total testosterone while also managing factors, such as insulin levels, that influence SHBG production. By directly influencing the unbound hormone fraction, clinicians can achieve a more precise and potent biological response at the cellular receptor level.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.